Related Experiment Videos
Cardiac involvement in Wegener's granulomatosis
N E Goodfield1, S Bhandari, W D Plant
1Department of Cardiology, Royal Infirmary, Edinburgh.
British Heart Journal
|February 1, 1995
Summary
Wegener's granulomatosis, a rare systemic vasculitis, can affect the heart in up to 44% of cases, often presenting subclinically. Early diagnosis using antineutrophil cytoplasmic antibody tests is crucial for managing this increasingly recognized condition.
Area of Science:
- Rheumatology
- Cardiology
- Internal Medicine
Background:
- Wegener's granulomatosis is a systemic inflammatory vasculitis with diverse clinical manifestations.
- Cardiac involvement in Wegener's granulomatosis is traditionally considered rare but may be underdiagnosed.
Observation:
- The protean clinical presentations depend on the organs involved and disease progression.
- Serological tests, such as antineutrophil cytoplasmic antibodies (ANCA), aid in diagnosing Wegener's granulomatosis, especially in atypical or early presentations.
- Cardiac involvement, including pericarditis, myocarditis, arteritis, valvulitis, and arrhythmias, may occur in up to 44% of patients.
Findings:
- Cardiac involvement can be subclinical or the primary source of symptoms.
- Wegener's granulomatosis should be considered in the differential diagnosis of non-specific cardiac conditions, including culture-negative endocarditis.
- Echocardiography and transesophageal echocardiography are valuable tools for identifying and assessing cardiac and aortic involvement.
Implications:
- Increased awareness of cardiac manifestations can lead to earlier diagnosis and treatment of Wegener's granulomatosis.
- Timely diagnosis and management can improve patient outcomes by addressing systemic inflammation and preventing cardiac complications.
- Advanced imaging techniques play a vital role in the comprehensive evaluation and monitoring of cardiac involvement in Wegener's granulomatosis.